Development and evaluation of the Korean version of the Gynecologic Cancer Lymphedema Questionnaire in gynecologic cancer survivors.
Identifieur interne : 001676 ( PubMed/Curation ); précédent : 001675; suivant : 001677Development and evaluation of the Korean version of the Gynecologic Cancer Lymphedema Questionnaire in gynecologic cancer survivors.
Auteurs : Myong Cheol Lim [Corée du Sud] ; Jeong Seon Lee [Corée du Sud] ; Jungnam Joo [Corée du Sud] ; Kibyung Park [Corée du Sud] ; Heon Jong Yoo [Corée du Sud] ; Sang-Soo Seo [Corée du Sud] ; Sokbom Kang [Corée du Sud] ; Seung Hyun Chung [Corée du Sud] ; Sang-Yoon Park [Corée du Sud]Source :
- Gynecologic oncology [ 1095-6859 ] ; 2014.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Aire sous la courbe, Caractéristiques culturelles, Enquêtes et questionnaires, Femelle, Humains, Langage, Lymphadénectomie (effets indésirables), Lymphoedème (diagnostic), Lymphoedème (étiologie), Reproductibilité des résultats, Sensibilité et spécificité, Sujet âgé, Sujet âgé de 80 ans ou plus, Tumeurs de l'endomètre (), Tumeurs de l'ovaire (), Tumeurs du col de l'utérus ().
- MESH :
- diagnostic : Lymphoedème.
- effets indésirables : Lymphadénectomie.
- étiologie : Lymphoedème.
- Adulte, Adulte d'âge moyen, Aire sous la courbe, Caractéristiques culturelles, Enquêtes et questionnaires, Femelle, Humains, Langage, Reproductibilité des résultats, Sensibilité et spécificité, Sujet âgé, Sujet âgé de 80 ans ou plus, Tumeurs de l'endomètre, Tumeurs de l'ovaire, Tumeurs du col de l'utérus.
English descriptors
- KwdEn :
- Adult, Aged, Aged, 80 and over, Area Under Curve, Cultural Characteristics, Endometrial Neoplasms (surgery), Female, Humans, Language, Lymph Node Excision (adverse effects), Lymphedema (diagnosis), Lymphedema (etiology), Middle Aged, Ovarian Neoplasms (surgery), Reproducibility of Results, Sensitivity and Specificity, Surveys and Questionnaires, Uterine Cervical Neoplasms (surgery).
- MESH :
- adverse effects : Lymph Node Excision.
- diagnosis : Lymphedema.
- etiology : Lymphedema.
- surgery : Endometrial Neoplasms, Ovarian Neoplasms, Uterine Cervical Neoplasms.
- Adult, Aged, Aged, 80 and over, Area Under Curve, Cultural Characteristics, Female, Humans, Language, Middle Aged, Reproducibility of Results, Sensitivity and Specificity, Surveys and Questionnaires.
Abstract
The purpose of this study was two-fold: first, to develop a Korean version of the Gynecologic Cancer Lymphedema Questionnaire (GCLQ-K) and evaluate its reliability and reproducibility and second, to examine the diagnostic efficacy of GCLQ-K in predicting lymphedema in gynecologic cancer survivors.
DOI: 10.1016/j.ygyno.2014.01.040
PubMed: 24522267
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001676
Links to Exploration step
pubmed:24522267Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Development and evaluation of the Korean version of the Gynecologic Cancer Lymphedema Questionnaire in gynecologic cancer survivors.</title><author><name sortKey="Lim, Myong Cheol" sort="Lim, Myong Cheol" uniqKey="Lim M" first="Myong Cheol" last="Lim">Myong Cheol Lim</name><affiliation wicri:level="1"><nlm:affiliation>Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769, Republic of Korea; Gynecologic Cancer Branch, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769, Republic of Korea. Electronic address: gynlim@gmail.com.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769, Republic of Korea; Gynecologic Cancer Branch, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769</wicri:regionArea></affiliation></author><author><name sortKey="Lee, Jeong Seon" sort="Lee, Jeong Seon" uniqKey="Lee J" first="Jeong Seon" last="Lee">Jeong Seon Lee</name><affiliation wicri:level="1"><nlm:affiliation>Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769, Republic of Korea.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769</wicri:regionArea></affiliation></author><author><name sortKey="Joo, Jungnam" sort="Joo, Jungnam" uniqKey="Joo J" first="Jungnam" last="Joo">Jungnam Joo</name><affiliation wicri:level="1"><nlm:affiliation>Biometric Research Branch, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769, Republic of Korea. Electronic address: Jooj@ncc.re.kr.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Biometric Research Branch, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769</wicri:regionArea></affiliation></author><author><name sortKey="Park, Kibyung" sort="Park, Kibyung" uniqKey="Park K" first="Kibyung" last="Park">Kibyung Park</name><affiliation wicri:level="1"><nlm:affiliation>Biometric Research Branch, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769, Republic of Korea.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Biometric Research Branch, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769</wicri:regionArea></affiliation></author><author><name sortKey="Yoo, Heon Jong" sort="Yoo, Heon Jong" uniqKey="Yoo H" first="Heon Jong" last="Yoo">Heon Jong Yoo</name><affiliation wicri:level="1"><nlm:affiliation>Department of Obstetrics & Gynecology, Chungnam National University Hospital, 33, Munhwa-ro, Jung-gu, Daejeon 301-721, Republic of Korea.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Department of Obstetrics & Gynecology, Chungnam National University Hospital, 33, Munhwa-ro, Jung-gu, Daejeon 301-721</wicri:regionArea></affiliation></author><author><name sortKey="Seo, Sang Soo" sort="Seo, Sang Soo" uniqKey="Seo S" first="Sang-Soo" last="Seo">Sang-Soo Seo</name><affiliation wicri:level="1"><nlm:affiliation>Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769, Republic of Korea.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769</wicri:regionArea></affiliation></author><author><name sortKey="Kang, Sokbom" sort="Kang, Sokbom" uniqKey="Kang S" first="Sokbom" last="Kang">Sokbom Kang</name><affiliation wicri:level="1"><nlm:affiliation>Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769, Republic of Korea; Gynecologic Cancer Branch, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769, Republic of Korea.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769, Republic of Korea; Gynecologic Cancer Branch, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769</wicri:regionArea></affiliation></author><author><name sortKey="Chung, Seung Hyun" sort="Chung, Seung Hyun" uniqKey="Chung S" first="Seung Hyun" last="Chung">Seung Hyun Chung</name><affiliation wicri:level="1"><nlm:affiliation>Rehabilitation Medicine, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769, Republic of Korea.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Rehabilitation Medicine, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769</wicri:regionArea></affiliation></author><author><name sortKey="Park, Sang Yoon" sort="Park, Sang Yoon" uniqKey="Park S" first="Sang-Yoon" last="Park">Sang-Yoon Park</name><affiliation wicri:level="1"><nlm:affiliation>Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769, Republic of Korea; Gynecologic Cancer Branch, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769, Republic of Korea. Electronic address: parksang@ncc.re.kr.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769, Republic of Korea; Gynecologic Cancer Branch, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:24522267</idno><idno type="pmid">24522267</idno><idno type="doi">10.1016/j.ygyno.2014.01.040</idno><idno type="wicri:Area/PubMed/Corpus">001676</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001676</idno><idno type="wicri:Area/PubMed/Curation">001676</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001676</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Development and evaluation of the Korean version of the Gynecologic Cancer Lymphedema Questionnaire in gynecologic cancer survivors.</title><author><name sortKey="Lim, Myong Cheol" sort="Lim, Myong Cheol" uniqKey="Lim M" first="Myong Cheol" last="Lim">Myong Cheol Lim</name><affiliation wicri:level="1"><nlm:affiliation>Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769, Republic of Korea; Gynecologic Cancer Branch, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769, Republic of Korea. Electronic address: gynlim@gmail.com.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769, Republic of Korea; Gynecologic Cancer Branch, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769</wicri:regionArea></affiliation></author><author><name sortKey="Lee, Jeong Seon" sort="Lee, Jeong Seon" uniqKey="Lee J" first="Jeong Seon" last="Lee">Jeong Seon Lee</name><affiliation wicri:level="1"><nlm:affiliation>Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769, Republic of Korea.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769</wicri:regionArea></affiliation></author><author><name sortKey="Joo, Jungnam" sort="Joo, Jungnam" uniqKey="Joo J" first="Jungnam" last="Joo">Jungnam Joo</name><affiliation wicri:level="1"><nlm:affiliation>Biometric Research Branch, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769, Republic of Korea. Electronic address: Jooj@ncc.re.kr.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Biometric Research Branch, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769</wicri:regionArea></affiliation></author><author><name sortKey="Park, Kibyung" sort="Park, Kibyung" uniqKey="Park K" first="Kibyung" last="Park">Kibyung Park</name><affiliation wicri:level="1"><nlm:affiliation>Biometric Research Branch, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769, Republic of Korea.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Biometric Research Branch, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769</wicri:regionArea></affiliation></author><author><name sortKey="Yoo, Heon Jong" sort="Yoo, Heon Jong" uniqKey="Yoo H" first="Heon Jong" last="Yoo">Heon Jong Yoo</name><affiliation wicri:level="1"><nlm:affiliation>Department of Obstetrics & Gynecology, Chungnam National University Hospital, 33, Munhwa-ro, Jung-gu, Daejeon 301-721, Republic of Korea.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Department of Obstetrics & Gynecology, Chungnam National University Hospital, 33, Munhwa-ro, Jung-gu, Daejeon 301-721</wicri:regionArea></affiliation></author><author><name sortKey="Seo, Sang Soo" sort="Seo, Sang Soo" uniqKey="Seo S" first="Sang-Soo" last="Seo">Sang-Soo Seo</name><affiliation wicri:level="1"><nlm:affiliation>Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769, Republic of Korea.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769</wicri:regionArea></affiliation></author><author><name sortKey="Kang, Sokbom" sort="Kang, Sokbom" uniqKey="Kang S" first="Sokbom" last="Kang">Sokbom Kang</name><affiliation wicri:level="1"><nlm:affiliation>Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769, Republic of Korea; Gynecologic Cancer Branch, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769, Republic of Korea.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769, Republic of Korea; Gynecologic Cancer Branch, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769</wicri:regionArea></affiliation></author><author><name sortKey="Chung, Seung Hyun" sort="Chung, Seung Hyun" uniqKey="Chung S" first="Seung Hyun" last="Chung">Seung Hyun Chung</name><affiliation wicri:level="1"><nlm:affiliation>Rehabilitation Medicine, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769, Republic of Korea.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Rehabilitation Medicine, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769</wicri:regionArea></affiliation></author><author><name sortKey="Park, Sang Yoon" sort="Park, Sang Yoon" uniqKey="Park S" first="Sang-Yoon" last="Park">Sang-Yoon Park</name><affiliation wicri:level="1"><nlm:affiliation>Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769, Republic of Korea; Gynecologic Cancer Branch, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769, Republic of Korea. Electronic address: parksang@ncc.re.kr.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769, Republic of Korea; Gynecologic Cancer Branch, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769</wicri:regionArea></affiliation></author></analytic><series><title level="j">Gynecologic oncology</title><idno type="eISSN">1095-6859</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Area Under Curve</term><term>Cultural Characteristics</term><term>Endometrial Neoplasms (surgery)</term><term>Female</term><term>Humans</term><term>Language</term><term>Lymph Node Excision (adverse effects)</term><term>Lymphedema (diagnosis)</term><term>Lymphedema (etiology)</term><term>Middle Aged</term><term>Ovarian Neoplasms (surgery)</term><term>Reproducibility of Results</term><term>Sensitivity and Specificity</term><term>Surveys and Questionnaires</term><term>Uterine Cervical Neoplasms (surgery)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Aire sous la courbe</term><term>Caractéristiques culturelles</term><term>Enquêtes et questionnaires</term><term>Femelle</term><term>Humains</term><term>Langage</term><term>Lymphadénectomie (effets indésirables)</term><term>Lymphoedème (diagnostic)</term><term>Lymphoedème (étiologie)</term><term>Reproductibilité des résultats</term><term>Sensibilité et spécificité</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Tumeurs de l'endomètre ()</term><term>Tumeurs de l'ovaire ()</term><term>Tumeurs du col de l'utérus ()</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Lymph Node Excision</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Lymphadénectomie</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Endometrial Neoplasms</term><term>Ovarian Neoplasms</term><term>Uterine Cervical Neoplasms</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Area Under Curve</term><term>Cultural Characteristics</term><term>Female</term><term>Humans</term><term>Language</term><term>Middle Aged</term><term>Reproducibility of Results</term><term>Sensitivity and Specificity</term><term>Surveys and Questionnaires</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Aire sous la courbe</term><term>Caractéristiques culturelles</term><term>Enquêtes et questionnaires</term><term>Femelle</term><term>Humains</term><term>Langage</term><term>Reproductibilité des résultats</term><term>Sensibilité et spécificité</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Tumeurs de l'endomètre</term><term>Tumeurs de l'ovaire</term><term>Tumeurs du col de l'utérus</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The purpose of this study was two-fold: first, to develop a Korean version of the Gynecologic Cancer Lymphedema Questionnaire (GCLQ-K) and evaluate its reliability and reproducibility and second, to examine the diagnostic efficacy of GCLQ-K in predicting lymphedema in gynecologic cancer survivors.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24522267</PMID><DateCreated><Year>2014</Year><Month>03</Month><Day>31</Day></DateCreated><DateCompleted><Year>2014</Year><Month>05</Month><Day>13</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-6859</ISSN><JournalIssue CitedMedium="Internet"><Volume>133</Volume><Issue>1</Issue><PubDate><Year>2014</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Gynecologic oncology</Title><ISOAbbreviation>Gynecol. Oncol.</ISOAbbreviation></Journal><ArticleTitle>Development and evaluation of the Korean version of the Gynecologic Cancer Lymphedema Questionnaire in gynecologic cancer survivors.</ArticleTitle><Pagination><MedlinePgn>111-6</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ygyno.2014.01.040</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0090-8258(14)00100-0</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The purpose of this study was two-fold: first, to develop a Korean version of the Gynecologic Cancer Lymphedema Questionnaire (GCLQ-K) and evaluate its reliability and reproducibility and second, to examine the diagnostic efficacy of GCLQ-K in predicting lymphedema in gynecologic cancer survivors.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We designed a case-control study, and the GCLQ-K was completed by 33 gynecologic cancer survivors with lymphedema and 34 gynecologic cancer survivors without lymphedema. A follow-up GCLQ-K was completed 3weeks after the baseline questionnaire.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The GCLQ-K showed high reliability with a Cronbach's α of 0.83 and high reproducibility with an intraclass correlation of 0.96. Of the 7 symptom clusters, 6 identified patients with lymphedema with statistical significance; identification of lymphedema using the physical functioning and infection-related symptom clusters did not reach significance. The area under the receiver operating characteristic curve (AUC) to distinguish patients with and without lymphedema was 0.868 (95% confidence interval [CI], 0.779-0.956). Following the exclusion of the physical functioning and infection-related symptom clusters, which showed poor prediction value for lymphedema, the AUC of the GCLQ-K total score further improved to 0.922 (95% CI, 0.864-0.981).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The GCLQ-K was successfully developed with minimal modifications to adapt the original GCLQ to the Korean culture and showed high internal consistency and reproducibility. Moreover, gynecologic cancer survivors with and without lymphedema could be satisfactorily distinguished using the GCLQ-K. Thus, GCLQ-K was proven to be a reliable tool, capable of identifying lymphedema in Korean gynecological cancer survivors.</AbstractText><CopyrightInformation>Copyright © 2014 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Myong Cheol</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769, Republic of Korea; Gynecologic Cancer Branch, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769, Republic of Korea. Electronic address: gynlim@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jeong Seon</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joo</LastName><ForeName>Jungnam</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Biometric Research Branch, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769, Republic of Korea. Electronic address: Jooj@ncc.re.kr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Kibyung</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Biometric Research Branch, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoo</LastName><ForeName>Heon Jong</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department of Obstetrics & Gynecology, Chungnam National University Hospital, 33, Munhwa-ro, Jung-gu, Daejeon 301-721, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seo</LastName><ForeName>Sang-Soo</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Sokbom</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769, Republic of Korea; Gynecologic Cancer Branch, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Seung Hyun</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Rehabilitation Medicine, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Sang-Yoon</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769, Republic of Korea; Gynecologic Cancer Branch, Research Institute and Hospital, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769, Republic of Korea. Electronic address: parksang@ncc.re.kr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>02</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Gynecol Oncol</MedlineTA><NlmUniqueID>0365304</NlmUniqueID><ISSNLinking>0090-8258</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019540" MajorTopicYN="N">Area Under Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003466" MajorTopicYN="N">Cultural Characteristics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016889" MajorTopicYN="N">Endometrial Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007802" MajorTopicYN="N">Language</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008197" MajorTopicYN="N">Lymph Node Excision</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010051" MajorTopicYN="N">Ovarian Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="Y">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002583" MajorTopicYN="N">Uterine Cervical Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Gynecologic cancer</Keyword><Keyword MajorTopicYN="N">Gynecologic cancer lymphedema questionnaire</Keyword><Keyword MajorTopicYN="N">Lymphedema</Keyword><Keyword MajorTopicYN="N">Validation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>10</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>01</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>01</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>5</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24522267</ArticleId><ArticleId IdType="pii">S0090-8258(14)00100-0</ArticleId><ArticleId IdType="doi">10.1016/j.ygyno.2014.01.040</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001676 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001676 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:24522267
|texte= Development and evaluation of the Korean version of the Gynecologic Cancer Lymphedema Questionnaire in gynecologic cancer survivors.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:24522267" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |